Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6001
Innovator US Equity Ultra Buffer ETF January
UJAN
$256M
| $126K | ﹤0.01% |
2,782
+411
| +17% | +$18.3K |
2020 Q4
22 quarters
|
|
6002
Aemetis
AMTX
$115M
| $126K | ﹤0.01% |
76,807
-1,842
| -2% | -$4.5K |
2019 Q1
29 quarters
|
|
6003
Capital Group Global Equity ETF
CGGE
$3.3B
| $126K | ﹤0.01% |
3,573
+2,553
| +250% | +$85.5K |
2025 Q2
4 quarters
|
|
6004
SKYX Platforms
SKYX
$150M
| $126K | ﹤0.01% |
113,910
-24,238
| -18% | -$26.9K |
2022 Q1
17 quarters
|
|
6005
Orchestra BioMed
OBIO
$355M
| $126K | ﹤0.01% |
29,160
-6,479
| -18% | -$26.5K |
2023 Q1
13 quarters
|
|
6006
Smart Sand
SND
$224M
| $126K | ﹤0.01% |
25,083
+9,956
| +66% | +$50K |
2022 Q1
17 quarters
|
|
6007
Tortoise Global Water ETF
TBLU
$55M
| $126K | ﹤0.01% |
2,435
| – | – |
2022 Q4
14 quarters
|
|
6008
Yesway Inc
YSWY
$659M
| $125K | ﹤0.01% |
+6,174
| New | +$143K |
2026 Q2
0 quarters
|
|
6009
AdvisorShares Dorsey Wright FSM US Core ETF
DWUS
$122M
| $125K | ﹤0.01% |
1,966
| – | – |
2024 Q4
6 quarters
|
|
6010
Usio Inc
USIO
$78.1M
| $125K | ﹤0.01% |
50,289
-4,746
| -9% | -$7.01K |
2019 Q4
26 quarters
|
|
6011
PLAYSTUDIOS Inc
MYPS
$50.8M
| $125K | ﹤0.01% |
24,972
-1,766
| -7% | -$8.5K |
2021 Q2
20 quarters
|
|
6012
Beacon Unified Catalyst ETF
BSR
$34.1M
| $123K | ﹤0.01% |
4,052
+4,029
| +17,517% | +$121K |
2026 Q1
1 quarter
|
|
6013
Ohio Valley Banc Corp
OVBC
$214M
| $122K | ﹤0.01% |
2,820
-363
| -11% | -$16.8K |
2024 Q1
9 quarters
|
|
6014
Clene
CLNN
$52.3M
| $122K | ﹤0.01% |
19,858
+26
| +0.1% | +$162 |
2020 Q4
22 quarters
|
|
6015
Monarch Ambassador Income Index ETF
MAMB
$194M
| $122K | ﹤0.01% |
5,065
+748
| +17% | +$18.1K |
2025 Q4
2 quarters
|
|
6016
Innovator Laddered Allocation Power Buffer ETF
BUFF
$1.09B
| $122K | ﹤0.01% |
2,311
+2,016
| +683% | +$104K |
2022 Q3
15 quarters
|
|
6017
Goldgroup Mining
GORO
$580M
| $122K | ﹤0.01% |
24,138
+11,086
| +85% | +$60.5K |
2013 Q2
52 quarters
|
|
6018
FT Vest US Equity Moderate Buffer ETF August
GAUG
$424M
| $121K | ﹤0.01% |
2,930
| – | – |
2025 Q2
4 quarters
|
|
6019
InfraCap REIT Preferred ETF
PFFR
$114M
| $121K | ﹤0.01% |
6,973
+44
| +0.6% | +$777 |
2019 Q3
27 quarters
|
|
6020
RYTHM Inc
RYM
$41.9M
| $121K | ﹤0.01% |
4,759
| – | – |
2026 Q1
1 quarter
|
|
6021
Isabella Bank
ISBA
$286M
| $121K | ﹤0.01% |
3,067
-6,115
| -67% | -$262K |
2025 Q2
4 quarters
|
|
6022
Corvex Inc
MOVE
$301M
| $121K | ﹤0.01% |
+5,581
| New | +$98.7K |
2026 Q2
0 quarters
|
|
6023
First Trust Indxx Innovative Transaction & Process ETF
LEGR
$127M
| $121K | ﹤0.01% |
1,878
+81
| +5% | +$5.16K |
2021 Q3
19 quarters
|
|
6024
Oxford Square Capital
OXSQ
$143M
| $121K | ﹤0.01% |
91,343
+26,563
| +41% | +$42.5K |
2013 Q2
52 quarters
|
|
6025
Protalix BioTherapeutics
PLX
$224M
| $120K | ﹤0.01% |
51,676
-250,117
| -83% | -$530K |
2020 Q3
23 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.